NCT06468982

Brief Summary

The optimal timing of surgery in patients with acute myocardial infarction (AMI) and the utilization of preoperative intra-aortic balloon pumps (IABP) in these patients are subjects of ongoing discussion and disagreement. This study aimed to investigate the effects of preoperative IABP on troponin levels, surgical timing, and intraoperative and postoperative outcomes for patients with AMI who undergo coronary artery bypass grafting (CABG).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
8 months until next milestone

Results Posted

Study results publicly available

February 27, 2025

Completed
Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

2.7 years

First QC Date

June 17, 2024

Results QC Date

June 23, 2024

Last Update Submit

February 5, 2025

Conditions

Keywords

Acute myocardial infarctioncoronary artery bypass surgeryintra-aortic balloon pumphigh-sensitivity cardiac troponin I

Outcome Measures

Primary Outcomes (1)

  • High-Sensitivity Cardiac Troponin Levels From Days 0-7

    Daily repeated measurements of high-sensitivity cardiac troponin (hs-cTnI) on the ng/mL scale were compared between the two groups. The study hypothesizes that hs-cTnI levels decrease more rapidly in participants receiving IABP support compared to those without IABP. This decrease is posited to reflect a myocardial healing process.

    0-7 days

Secondary Outcomes (1)

  • In-hospital Mortality

    0-30 days

Study Arms (2)

Group A (IABP support)

ACTIVE COMPARATOR

Patients who are receiving intra-aortic balloon pump support during the preoperative period

Device: Intra-aortic Balloon Pump

Group B (control group; without IABP support)

NO INTERVENTION

Patients who did not receive intra-aortic balloon pump support in the preoperative period; control group

Interventions

It will be applied to patients with acute myocardial infarction who have elevated troponin levels and recurrent or persistent chest pain at rest, hemodynamic instability, multivascular disease, left main coronary artery disease, and patients with narrow and/or tortuous coronary artery anatomy in whom PCI has failed or is not applicable.

Also known as: Datascope Corp. model:The CS300 with IntelliSense combines fiber-optic
Group A (IABP support)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who have had acute myocardial infarction and have been decided on coronary surgical revascularization

You may not qualify if:

  • mechanical complications of Acute Myocardial Infarction (such as a ruptured chordal or ventricular septum)
  • peripheral arterial disease
  • renal failure
  • history of cerebrovascular accident
  • acute cardiogenic shock and cardiac arrest
  • reoperation and combined operations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Atatürk University

Yakutiye, Erzurum, 25100, Turkey (Türkiye)

Location

Atatürk University

Erzurum, 25100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Intra-Aortic Balloon Pumping

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

CounterpulsationAssisted CirculationSurgical Procedures, Operative

Limitations and Caveats

Not using more than one troponin test kit. The Swan-Ganz catheter or cardiac index device cannot be used in every patient.

Results Point of Contact

Title
Dr. Ümit Arslan
Organization
Atatürk University

Study Officials

  • Ümit Arslan, assoc prof

    Ataturk University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two groups for patients with acute myocardial infarction scheduled for coronary artery bypass Grafting: Group A with IABP support, and Group B (the control group) without IABP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

June 17, 2024

First Posted

June 21, 2024

Study Start

May 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

February 27, 2025

Results First Posted

February 27, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations